ID: ALA3920371

Max Phase: Preclinical

Molecular Formula: C17H14N2O3

Molecular Weight: 294.31

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(/C=C/c1ccc([N+](=O)[O-])cc1)N1CCc2ccccc21

Standard InChI:  InChI=1S/C17H14N2O3/c20-17(18-12-11-14-3-1-2-4-16(14)18)10-7-13-5-8-15(9-6-13)19(21)22/h1-10H,11-12H2/b10-7+

Standard InChI Key:  WPQIZPDOIZGDGQ-JXMROGBWSA-N

Associated Targets(non-human)

Protein-glutamine gamma-glutamyltransferase 2 55 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 294.31Molecular Weight (Monoisotopic): 294.1004AlogP: 3.20#Rotatable Bonds: 3
Polar Surface Area: 63.45Molecular Species: NEUTRALHBA: 3HBD: 0
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 3.41CX LogD: 3.41
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.50Np Likeness Score: -1.02

References

1.  (2015)  Cinnamoyl inhibitors of transglutaminase, 

Source

Source(1):